Search PubMedSearch

PubMed · 7418485

A general purpose microprocessor for spirometry.

Abstract

A portable, inexpensive microprocessor is described for on-line spirographic analysis of FVC and its time derivatives and MVV, using a primary flow or volume signal. Resolution is +/- 0.02 L and maximal collection time 66 seconds. Algorithms according to the Snowbird Conference recommendations include back extrapolation, "end of test" determination and the selection criteria for satisfactory tests, and best FVC, FEV1 and other flow rates. Differentiation is digital and flow-volume outputs are available. Actual, predicted and percent predicted values for children or adults are displayed, or can be printed together with an interpretation and a flow-volume loop. Four hundred tests with a Stead-Wells spirometer, a pneumotachograph and a turbinometer using an explosive decompression FVC simulator showed standard deviations of +/- 0.04 L or L/sec or less, except for peak flow. Differences between microprocessor values and tracing analyses were less than 0.04 L. MVV with a reciprocating pump equalled exactly the MVV calculated from stroke volume and frequency (r = .999) from 8 to 325 L/min. Tests of 168 patients were comparable to the calibration devices.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K H Black, M L Petusevsky, E A Gaensler. 1980. A general purpose microprocessor for spirometry.. https://doi.org/10.1378/chest.78.4.605

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The promise of computerized feedback systems for diabetes care.

Feedback control is an important mechanism for reaching a targeted goal. Biologic examples range from achieving the appropriate blood pressure level to glycemia control. Computer-based feedback control systems have many potential applications in medicine. Closed-loop systems directly sense the state of the patient and then deliver an intervention without human action. Closed-loop systems have been used to control postoperative fluid infusion, reduce malignant hypertension to a reasonable range through nitroprusside infusions, and control continuous insulin infusions-in effect, an artificial pancreas. Sensory problems have limited the direct application of closed-loop systems to date; most current medical uses of computer-based feedback control are open loop, where a human is interposed between the suggested intervention and the delivered treatment. Because many variables important to the management of diabetes are objective, many opportunities exist for open-loop control in diabetes management. Open-loop systems have already been used to suggest insulin dosage adjustments and treatment for hypercholesterolemia and to remind physicians of various mellitus. However, existing applications have only scratched the surface. Many more facets of diabetes management could be standardized and assisted by open-loop control systems if the management rules could be more exactly specified, a task requiring substantial time commitments by diabetologists. Efforts to translate existing knowledge bases into precise guidelines will be helpful, but new primary studies and decision analyses are needed to define the optimal use of some interventions.

Computers